A pproximately 700,000 people experience a new or recurrent stroke each year in the United States. After heart disease and cancer, stroke ranks third among all causes of death, accounting for about 1 in every 16 deaths in 2004. In 2001, $3.7 billion was paid to Medicare beneficiaries discharged from short-stay hospitals with stroke (1) . These statistics have prompted a number of researchers to evaluate the role of intensive care unit (ICU) management of stroke patients in terms of its impact on survival and functional outcomes. The effect on health care expenditure is also of interest, because ICU patients account for 20% to 40% of all hospital costs (2) . Accurate knowledge of such outcomes and resource consumption is important to clinicians, healthcare administrators, and policy makers alike to help guide decision-making. However, very few studies have been carried out in this field in the United States.
Mortality rates in ICU patients with stroke range from 15% to 59% in the short term (Յ3 months) (3) (4) (5) (6) . The wide variation in reported death rates is related to a number of factors. Firstly, studies have been conducted in a number of countries, likely with differing practices in the ICU management of stroke. Secondly, very small numbers of patients have been included, ranging from 58 to 138, mostly in single centers (3-5, 7, 8) . Finally, there has been no uniformity in the type of stroke patient studied, with reports including either hemorrhagic stroke, ischemic stroke, or both. Only one study has, thus far, addressed the issue of long-term survival; the study was conducted in Spain and reported a 1-yr mortality of 66% in acute ischemic stroke patients admitted to ICU (4) .
Mechanical ventilation (MV) and percutaneous gastrostomy tubes (PEGs) in the setting of stroke have also been the subject of prior investigations, because their use is associated with a considerable increase in resource consumption. Mechanical ventilation has been demonstrated to be a proxy for stroke severity and coma (9) ; reported mortality rates in these patients have been much higher, ranging between 46% and 92% (10 -21) . Almost all previous studies have been case-series analyses. The largest report to date was that by Bushnell et al (11) who conducted a retrospective chart review of 131 mechanically ventilated stroke patients, reporting a 30-day mortality of 49% and a 6-month mortality of 61%.
Ours is the first large-scale study aiming to establish the long-term outcome in older patients hospitalized with acute ischemic stroke in the United States. Our objective was to compare the survival of patients with acute ischemic stroke admitted to ICUs with those not requiring ICU care (non-ICU patients) using a multicentered retrospective cohort study design. Our study is also the first with sufficient power to also analyze the separate effects of MV and PEG insertion on longterm outcome.
MATERIALS AND METHODS

Population and Sampling
We identified Medicare beneficiaries Ն65 yrs of age discharged with acute ischemic stroke during 2000 in 11 metropolitan regions of the country. Patients were included in the sample if they had an International Classification of Diseases, 9th Edition (ICD-9) diagnosis code of 434 or 436 in the first position on the discharge diagnosis list from an acute care hospitalization, which has been found to accurately identify acute ischemic stroke in 89% to 90% of cases (22) . If a patient had more than one acute ischemic stroke discharge over the study period, one discharge was randomly selected. This approach obviated the need for analyses accounting for repeated observations on the same patient. However, the number of patients with repeated strokes is small, with Ͻ3% of patients having a second stroke during 2000.
We obtained health maintenance organization (HMO) data from a large national managed care organization and FFS (fee for service) data from the Centers for Medicare and Medicaid Services. HMO data included patients who were enrolled in 11 Medicare Plus Choice plans serving 93 metropolitan counties primarily in the eastern half of the United States (n ϭ 1939 patients with acute ischemic stroke in 422 hospitals). Comparable data were obtained for all FFS patients (n ϭ 29,850) discharged with acute ischemic stroke in the same counties. This study was approved by the Institutional Review Board of the University of Wisconsin.
Data Extraction
We utilized enrollment data and final institutional and physician/supplier claims for all study patients from 1 yr before their index hospital admission date up to the time of their death or until 12 months after the date of their index hospitalization. Both HMO and FFS patients had claims submitted using standard Centers for Medicare and Medicaid Services forms. For HMO patients, we also obtained enrollment and disenrollment data and all claims submitted to the HMO from out-ofnetwork facilities. For both FFS and HMO patients, we obtained the Medicare denominator file to determine age, sex, race, Zip code, Medicaid enrollment, and date of death. This file was used to exclude FFS beneficiaries who were missing Medicare Part A or Part B coverage, had end-stage renal disease, received railroad retirement benefits, or were enrolled in an HMO at any point from 1 yr before their index hospitalization to the time of their death.
Variables
The main dependent variable was mortality at any time following the index hospital admission date up to the end of the follow-up period. Explanatory variables included ICU admission and two validated indicator variables representing disease severity, namely mechanical ventilation (CPT 94656, 94657; ICD-9 96.7x) (9) and placement or revision of a gastrostomy tube (CPT 43750, 43760, 43761, 43832, 43246; ICD-9 43.11) (23) . An ICU admission was identified using the Centers for Medicare and Medicaid Services revenue codes indicating billing for an ICU stay (revenue codes 020x, in which x ranges from 0 to 9). This includes the following types of ICUs: general, surgical, medical, pediatric, psychiatric, intermediate ICU, burn care, trauma, and other intensive care.
We included individual and neighborhood sociodemographic characteristics as potential confounder variables. Individual characteristics comprised age, gender, race, and an indicator identifying beneficiaries with low to modest income who are fully enrolled in Medicaid, or received some help with Medicare cost-sharing through Medicaid. ZIPϩ4 information was used to link patient data to the corresponding 2000 census block group and obtain neighborhood socioeconomic characteristics, including percent over 24 yrs of age with college degree and percent below poverty line (24) .
It is critical to control for pre-existing differences in comorbidity between comparison groups, namely those admitted to the ICU and non-ICU patients. We identified 30 comorbid conditions that incorporated information from the initial hospitalization, all hospitalizations, and all physician claims during the prior year using methods proposed by Elixhauser et al (25) and Klabunde et al (26) . Of these 30 conditions, we included the 13 comorbidities present in over 5% of our sample as indicator variables. An "other comorbidity count" was generated for the remaining conditions present in Ͻ5% of our sample. We also coded the following: hospitalization during the year before the index hospitalization, dementia (27) , stroke during the year before the index hospitalization (28) , and concurrent cardiac events (acute myocardial infarction, unstable angina pectoris, coronary artery bypass graft, and cardiac catheterization) (29) . Additionally, the Centers for Medicare and Medicaid Services' hierarchical condition categories score for the year before admission was calculated for each subject and included in models as a comprehensive risk adjustment measure (30) .
Analysis
Analyses were conducted using Stata version 9.0. A two-sided p value of Ͻ.05 was considered to be statistically significant. Baseline descriptive data were compared with analysis of variance for continuous variables and the chi-squared test for categorical variables. Kaplan-Meier survival curves were constructed to describe crude differences in mortality between comparison groups. The logrank test was used to assess the significance of any differences observed.
The probability of death in patients who were admitted to the ICU was estimated using logistic regression. Unadjusted and adjusted probabilities were calculated for 30 days from the time of admission and, in 30-day survivors, for 12 months from the date of admission. These probabilities were estimated separately according to combinations of the presence/ absence of MV and PEGs. This was achieved by including two-way interaction terms between MV and PEG indicator variables in the logistic regression models. The 95% predicted probabilities and confidence intervals (CIs) were constructed using the "prvalue" command in Stata, using the delta method to construct CIs.
The association between ICU admission, MV, PEG, and survival rate was evaluated using Cox proportional hazards regression. Because these variables showed evidence of nonproportional mortality hazard ratios [HRs] over time, analyses were carried out separately for deaths occurring within 30 days of admission and those occurring between 30 days (conditional upon survival to 30 days) and the end of the follow-up period, which was 12 months after the date of index hospitalization. Nonproportionality of hazards was assessed using Schoenfeld residuals. All modeling was carried out using robust estimates of variance that allowed for clustering of patients within hospitals.
RESULTS
Study Population
A total of 31,301 patients were included in the study. Of the patients, 26% were admitted to an ICU at some point during their index hospitalization. These ICU patients were slightly older than their non-ICU counterparts, with patients Ͻ80 yrs being more likely to be admitted to the ICU than those Ͼ80 (Table 1) . ICU patients were more likely to be male (39.2% vs. 36.8%, p Ͻ .000), to be enrolled in a managed care organization (6.8% vs. 6.0%, p ϭ .01) and live in an area with a lower attained level of education (23% in block group with a college degree vs. 25%, p Ͻ .000). Medicaid eligibility, white race, and the poverty level of the area in which patients lived were not related to the likelihood of ICU admission; however, African Americans were less likely (12.9% vs. 14.3%, p ϭ .001) and other minorities were more likely (5% vs. 3.2%, p Ͻ .000) to be admitted to the ICU. As expected, the likelihood of MV and PEG placement was higher in ICU than in non-ICU patients. Specifically, 10.7% of ICU patients were mechanically ventilated compared with 0.8% of non-ICU patients (p Ͻ .000), and 11.1% had placement or revision of a percutaneous gastrostomy in the ICU compared with 5.6% outside of the ICU (p Ͻ .000). At the end of their hospitalization, non-ICU patients were slightly more likely to be discharged home (30% vs. 28%, p Ͻ .000).
Differences in comorbidities were noted in the comparison groups (Table 2) .
Specifically, risk adjustment hierarchical condition categories scores were higher in ICU patients (mean score, 2.53 Ϯ 1.39 vs. 2.30 Ϯ 1.30; p Ͻ .000). Comorbidities that were significantly more likely in ICU patients were cardiac arrhythmias, congestive heart failure, chronic pulmonary disease, fluid and electrolyte disorders, valvular heart disease, and concurrent cardiac events. Non-ICU patients, on the other hand, were more likely to have had a prior stroke, peripheral vascular disease, hypothyroidism, depression, and dementia. The remainder of the specific disease entities that were evaluated had no impact on the likelihood of ICU admission.
Crude Mortality Rates Figure 1 shows the Kaplan-Meier survival curves for patients admitted with ischemic stroke at 30 days and at 12 months, conditional upon 30-day survival. Absolute mortality rates are presented in Table 3 . The overall death rate was 15% at 30 days and 34% at 1-yr follow-up. Crude 30-day mortality was significantly higher among ICU patients (21% vs. 13%; log-rank test p Ͻ .000), ventilated patients (65% vs. 14%; log- 
Adjusted Hazard Ratios
The results of Cox multivariable regression analysis are presented in Table  4 . At 30 days, after adjustment for sociodemographic variables, comorbidities, and the use of MV and PEG, the mortality hazard remained 29% higher in ICU patients (HR 1.29, 95% CI 1.18 -1.40; p Ͻ .000). The use of MV was associated with more than a five-fold increase in mortality hazard (HR 5.59, 95% CI 4.93-6.34; p Ͻ .000), while PEG insertion or revision had no impact (HR 0.96, 95% CI 0.85-1.07).
In those who survived the initial 30 days, however, ICU admission had no significant impact on 1-yr mortality (HR 1.01, 95% CI 0.93-1.09; p ϭ .869). MV still resulted in a higher risk of death, although with a decreased HR compared with the 30-day effect (HR 1.88, 95% CI 1.57-2.25; p Ͻ .000). At this time, patients with a PEG tube had a 2.59-fold greater hazard of death than non-PEG patients (95% CI 2.38 -2.82; p Ͻ .000).
Age was associated with a gradually increasing risk of death, with those Ͼ85 having more than a three-fold increase in mortality hazard, both at 30 days and 1 yr, when compared with the baseline group of patients ages 65 to 70 yrs. Of the comorbidities examined, the strongest association with mortality was seen with arrhythmias, congestive heart failure, valvular heart disease, and hypothyroidism. Increased risk of death was also seen in those who had concomitant chronic obstructive pulmonary disease, diabetes mellitus, hypertension, solid tumors, and dementia.
DISCUSSION
Summary of Study Findings
ICU admission was associated with increased 30-day mortality among older stroke patients requiring hospitalization in the United States. However, in 30-day survivors, ICU admission had no impact on long-term, 1-yr mortality after adjustment for sociodemographic variables and comorbidities. Our data demonstrate that patients who received MV in the setting of acute ischemic stroke had a significantly higher probability of death, both in the short term and at 1 yr following the index hospitalization. By contrast, those who received a PEG did not have a higher 30-day mortality, but demonstrated a markedly increased risk of death at 1 yr.
Explanation and Relation to Previous Work
There are a number of indications for the admission of acute stroke patients to the ICU. Most commonly, these are deteriorating neurological status, the need for thrombolytic therapy, brainstem infarcts referable to the basilar artery, and large space-occupying hemispheric infarcts (31, 32) . Other indications include fluctuating hemodynamically induced infarction, multiple or septic emboli, to the ICU of a single tertiary care center (5, 8) . A number of other investigations outside of the United States have been reported, mostly with very small patient numbers. The largest to date is by Navarrete-Navarro et al, who performed a multicenter, prospective observational study of 132 stroke patients admitted to ICUs in Spain (4): 74% of patients required MV. One-yr mortality was 66% in the subgroup of patients (n ϭ 27) who had ischemic stroke. A larger study in Taiwan has been completed involving 850 stroke patients admitted to ICUs, 508 of whom suffered ischemic stroke (6) . However, this study has very limited comparability to ours, given the much younger patient population and different care practices such as a strikingly longer average length of stay. MV is another important reason for ICU admission of stroke patients. Indications for MV in acute ischemic stroke include deteriorating level of consciousness, airway compromise, seizures and respiratory failure due to pneumonia, pulmonary edema (cardiogenic or noncardiogenic), and pulmonary embolism (10, 15, 16, 21) . Our study demonstrates that patients requiring MV experience a significantly higher mortality, both at 30 days and at 1 yr, when compared with stroke patients not requiring MV. Most previous studies have focused on ICU or in-hospital mortality. However, shortterm (Յ3 months) mortality has been reported to be in the range 46% to 90% (7, 10, 11, 15, 16, 20, 34 -37) ; this compares to a 30-day mortality in our sample of 65%. Older and smaller studies have generally reported higher mortality rates. The extent to which the changing practice of MV contributes to the observed decreasing trend in mortality remains uncertain. Aggregate 1-yr mortality for mechanically ventilated patients in our study population also remained high at 82%. It has been argued that the need for MV in the setting of stroke is a proxy for coma (9) . This would certainly be true if the indication for MV was always related to the stroke process. However, other ongoing processes such as cardiac or respiratory failure or pulmonary embolism may also be markers for greater illness severity due to comorbidities and thus will be associated with a higher mortality rate. This may partially explain why the effect of MV is much less after 30 days.
Early reports in the 1990s suggested that stroke patients with dysphagia may have improved outcomes if they receive enteral nutrition via a gastrostomy tube (38, 39) . A single center cohort study in the United States looked at stroke patients with a PEG admitted to a rehabilitation facility (40) . Mortality after a mean follow-up of 2 yrs was 36%. However, a matched case-control study, also focusing on stroke patients at a rehabilitation center, showed that those with a PEG were at increased risk of complications and death (41) . More recently, a multicenter randomized trial evaluated feeding policies in hospitalized patients with recent stroke (42) . Three separate trials were conducted as part of this study. In one, the benefit of early tube feeding was assessed in 859 dysphagic stroke patients and revealed an absolute reduction of death rate of 5.8% at 6 months follow-up. In another trial, feeding via PEG was compared with a nasogastric tube. In all, 329 patients were recruited; there was no statistically significant difference in the risk of death between the two groups (42) . In our study, we have shown that there was no increased risk of death at 30 days in PEG patients (adjusted HR 0.96). If it is assumed that patients requiring a PEG have either a greater severity of dysphagia or a greater severity of stroke itself, then one may postulate that PEG offers a shortterm survival advantage, because these patients may otherwise be expected to have a higher death rate. We believe, however, that our findings are the result of a selection effect, whereby the decision to place a PEG by the clinician staff, patients, and families is made only in those who are deemed to have a reasonable chance of survival, at least in the short term. Certainly, this advantage is not evident at 12-month follow-up, when the adjusted HR increased to 2.59. Thus, in those who survive the initial 30 days, the need for a PEG appears to be a better predictor of long-term mortality.
The principal strength of our study lies in its generalizability to other older patients suffering from ischemic stroke in the United States by virtue of the size and geographical distribution of the sample. We were able to adjust for confounding factors, including comorbidities (25) , illness severity (30) , and sociodemographic variables. However, we did not have access to stroke-specific severity information such as infarct size and territory, the Glasgow Coma Scale, or disability scores that have, in smaller studies, been shown to be predictors of mortality. The impact of specific therapeutics such as the use of thrombolytic agents could not be analyzed owing to lack of information on these interventions. Furthermore, we did not have data on the functional status of survivors at 12 months. Such data would have been informative, in particular with regards to assessment of patients who did require ICU care or interventions such as MV and PEG.
CONCLUSIONS
Both short-term and long-term mortality in older patients with acute ischemic stroke admitted to ICUs is lower than previously reported. The same is true for patients who require MV and survive the initial phase of their illness. The need for PEG does appear to be a marker for poor long-term prognosis. Clearly, the care given to stroke patients during the initial hospitalization is related to their long-term outcome. Older age per se should, therefore, not be considered a contraindication to the delivery of intensive care in this setting. The course of events after hospital discharge is less well understood. In patients who require MV or PEG, what clinical factors lead to the lower observed survival rate? Is there a greater incidence of aspiration pneumonia or cardiac failure, for example? Understanding the underlying causes will lead to identification of potentially reversible events, ultimately resulting in improved care and reduced death rates. Future research should focus on delineating such clinical factors, on strokespecific predictors of long-term survival in patients requiring ICU care, and on their functional outcomes.
